Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May 4;49(9):2673-6.
doi: 10.1021/jm051196m.

Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity

Affiliations

Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity

Sheela K Chellappan et al. J Med Chem. .

Abstract

We report the synthesis and pharmacological properties of several cytisine derivatives. Among them, two 10-substituted derivatives showed much higher selectivities for the alpha4beta2 nAChR subtype in binding assays than cytisine. The 9-vinyl derivative was found to have a very similar agonist activity profile to that of cytisine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Scheme 1
Scheme 1
aReagents and conditions: (a) BH3-THF, THF, 0 °C, 5 h, 85%; (b) CH2(OMe)2, BF3·OEt2, CH2Cl2, 0 °C, 3 h, 85%.
Scheme 2
Scheme 2
aReagents and conditions: (a) Pd(PPh3)4, DMF, 130 °C, 15 h, 79%; (b) LiAlH4, THF, -20 °C, 3.5 h, 59%; (c) BnBr, CH3CN, reflux, 2 h; (d) H2 (1 atm), PtO2, Et3N, MeOH, rt, 15 h, cis : trans = 5:1; cis, 67%; (e) MsCl, Et3N, DCM, 0 °C, 30 min, 84%; (f) Toluene, reflux, 3 h, 83%; (g) TFA, rt, 3 h, 91%; (h) H2 (1 atm), 10% Pd-C (1eq w/w), MeOH, rt, 15 h; (i) H2 (1 atm), 20% Pd(OH)2-C (0.1 eq), (Boc)2O, MeOH, reflux, 30 min, 92%; (j) TFA, CH2Cl2, rt, 1 h, 87-93%.
Scheme 3
Scheme 3
aReagents and conditions: (a) PdCl2(PPh3)2, Dioxane, 120 °C, 1 h, 73%; (b) TFA, CH2Cl2, 30 min, 81%. (c) Pd (PPh3)4, K2CO3, DME/H2O, 85 °C, 15 h, 87%; (d) TFA, CH2Cl2, 30 min, 85%.

Similar articles

Cited by

References

    1. Holladay MW, Dart MJ, Lynch JK. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 1997;40:4169–4194. - PubMed
    1. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 2002;3:102–114. - PubMed
    2. Jensen AA, Frølund B, Liljefors T, Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 2005;48:4705–4745. - PubMed
    1. Hogg RC, Bertrand D. Nicotinic acetylcholine receptors as drug targets. Curr. Drug. Targets. CNS Neurol. Disord. 2004;3:123–130. - PubMed
    2. Clementi F, Fornasari D, Gotti C. Neuronal nicotinic acetylcholine receptors: from structure to therapeutics. Trends Pharmacol Sci. 2000;21:35–37. - PubMed
    3. Kellar KJ, Dâavila-Garcâia MI, Xiao Y. Pharmacology of neuronal nicotinic acetylcholine recceptors: effects of acute and chronic nicotine. Nicotine Tob. Res. 1999;1:S117–120. discussion S139-140. - PubMed
    4. Daly JW. Nicotinic Agonists, Antagonists and Modulators From Natural Sources. Cell. Mol. Neurobiol. 2005;25:513–551. - PMC - PubMed
    1. Millar NS. Assembly and subunit diversity of nicotinic acetylcholine receptors. Biochem. Soc. Trans. 2003;31:869–874. - PubMed
    1. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 2004;74:363–396. - PubMed

Publication types

MeSH terms